Recent News for NMDBF - Neonmind Biosciences Inc

Date Title
Mar 11 NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
Feb 24 NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial
Back to the Main NMDBF Page...